35ye: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "35ye": Seeded page ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 35ye is ON HOLD | The entry 35ye is ON HOLD until Paper Publication | ||
Authors: Biehl, S., Mateus, S., Maganathan, N., Norris, J., Broni, E., Zak, D., Fink, E., Young, K., Hancock, G., Miller, W., McDonnel, D.P., Willson, T., Fanning, S.W. | Authors: Biehl, S., Mateus, S., Maganathan, N., Norris, J., Broni, E., Zak, D., Fink, E., Young, K., Hancock, G., Miller, W., McDonnel, D.P., Willson, T., Fanning, S.W. | ||
| Line 7: | Line 7: | ||
Description: Estrogen Receptor Alpha Ligand Binding Domain in Complex with 2-{6-chloro-3-[3-(2-iodoethyloxy)phenyl]-1-thia-5,7-diazainden-4-yl}isoindolin-5-ol | Description: Estrogen Receptor Alpha Ligand Binding Domain in Complex with 2-{6-chloro-3-[3-(2-iodoethyloxy)phenyl]-1-thia-5,7-diazainden-4-yl}isoindolin-5-ol | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: Mcdonnel, D.P]] | |||
[[Category: Hancock, G]] | |||
[[Category: Fink, E]] | |||
[[Category: Willson, T]] | [[Category: Willson, T]] | ||
[[Category: | [[Category: Broni, E]] | ||
[[Category: Miller, W]] | [[Category: Miller, W]] | ||
[[Category: Young, K]] | |||
[[Category: Zak, D]] | [[Category: Zak, D]] | ||
[[Category: | [[Category: Mateus, S]] | ||
[[Category: | [[Category: Biehl, S]] | ||
[[Category: Fanning, S.W]] | [[Category: Fanning, S.W]] | ||
[[Category: Maganathan, N]] | |||
[[Category: Norris, J]] | [[Category: Norris, J]] | ||
Latest revision as of 12:16, 1 July 2026
Unreleased structure
The entry 35ye is ON HOLD until Paper Publication
Authors: Biehl, S., Mateus, S., Maganathan, N., Norris, J., Broni, E., Zak, D., Fink, E., Young, K., Hancock, G., Miller, W., McDonnel, D.P., Willson, T., Fanning, S.W.
Description: Estrogen Receptor Alpha Ligand Binding Domain in Complex with 2-{6-chloro-3-[3-(2-iodoethyloxy)phenyl]-1-thia-5,7-diazainden-4-yl}isoindolin-5-ol
